GNWRX
Price
$31.19
Change
+$0.10 (+0.32%)
Updated
Jun 12 closing price
Net Assets
1.72B
VFFSX
Price
$296.49
Change
+$1.14 (+0.39%)
Updated
Jun 12 closing price
Net Assets
1.43T
Interact to see
Advertisement

GNWRX vs VFFSX

Header iconGNWRX vs VFFSX Comparison
Open Charts GNWRX vs VFFSXBanner chart's image
Nationwide R
Price$31.19
Change+$0.10 (+0.32%)
VolumeN/A
Net Assets1.72B
Vanguard 500 Index Institutional Select
Price$296.49
Change+$1.14 (+0.39%)
VolumeN/A
Net Assets1.43T
GNWRX vs VFFSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GNWRX vs. VFFSX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNWRX is a Buy and VFFSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.43T vs. GNWRX (1.72B). VFFSX pays higher dividends than GNWRX: VFFSX (1.29) vs GNWRX (0.06). GNWRX was incepted earlier than VFFSX: GNWRX (22 years) vs VFFSX (9 years). GNWRX (1.34) is less costly to investors than VFFSX (0.01). GNWRX is a more actively managed with annual turnover of: 83.61 vs. VFFSX (2.00). GNWRX has a lower initial minimum investment than VFFSX: GNWRX (0) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 11.14 vs. GNWRX (-1.18). VFFSX return over 5 years is better than : 97.92 vs. GNWRX (41.59).
GNWRXVFFSXGNWRX / VFFSX
Total Expense Ratio1.300.0113,000%
Annual Report Gross Expense Ratio1.340.0113,400%
Fund Existence22 years9 years-
Gain YTD2.5732.65697%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.72B1.43T0%
Annual Yield % from dividends0.061.295%
Returns for 1 year-1.1811.14-11%
Returns for 3 years35.6960.7259%
Returns for 5 years41.5997.9242%
Returns for 10 years41.51N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TAK15.390.22
+1.45%
Takeda Pharmaceutical Company Limited
FELE86.32-0.58
-0.67%
Franklin Electric Co
GPCR22.22-0.50
-2.20%
Structure Therapeutics
GLUE4.92-0.13
-2.57%
Monte Rosa Therapeutics
LTRN3.23-0.15
-4.44%
Lantern Pharma